Product Information
LYRICA 25 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $9.6834 per EA under NDC 58151023677. Its NADAC has been published 80 times since Feb 12, 2025.
FDA first approved this application on Dec 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151023677
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PREGABALINApproval Type
New Drug (NDA)
FDA Application
NDA021446FDA Approved
12/30/2004
TE Code
AB
On Market Since
11/19/2024
Price Statistics
The NADAC for LYRICA 25 MG CAPSULE has been published 80 times since Feb 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6834 per EA |
|---|---|
| All-time high | $9.7148 (May 13, 2026) |
| All-time low | $9.6712 (May 21, 2025) |
| 52-week high | $9.7148 |
| 52-week low | $9.6798 |
| Median price | $9.6961 |
| Average price | $9.6951 |
| Largest weekly change | -0.3% (May 21, 2025) |
| Weeks tracked | 80 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LYRICA 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LYRICA 25 MG CAPSULE, manufactured by Viatris Specialty LLC, is $9.6834 per EA (NDC 58151023677), effective Aug 19, 2026.
How has the price of LYRICA 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LYRICA 25 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 80 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for LYRICA 25 MG CAPSULE?
Since Feb 12, 2025, the NADAC for LYRICA 25 MG CAPSULE has ranged from a low of $9.6712 (May 21, 2025) to a high of $9.7148 (May 13, 2026), with a median of $9.6961 per EA.
Are there cheaper alternatives to LYRICA 25 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 25 MG CAPSULE, is $0.0406 per EA — about 99% below LYRICA 25 MG CAPSULE.
Who manufactures LYRICA 25 MG CAPSULE?
LYRICA 25 MG CAPSULE (NDC 58151023677) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.